임상시험 트래커
추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov
기업
60건 표시 (상위 60건)
- 2상모집 중· Colon and Rectal CancerGemcitabine, Cisplatin, Nab-paclitaxel (GAP) and Cemiplimab for Locally Advanced Biliary Tract Cancer (BTC)
협력: 리제네론
- 2상모집 중· Non-small Cell Lung Cancer Stage IIINeoadjuvant Chemo-Immunotherapy and Surgical Resection in Locally Advanced Non-small Cell Lung Cancer With N3 Lymph Node Involvement
협력: 리제네론
- 3상모집 중· Peripheral Artery Disease (PAD)Reducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With Peripheral Artery Disease
리드: 리제네론
- 3상모집 중· Venous Thromboembolism (VTE)Treatment and Secondary Prevention of Venous Thromboembolism (VTE) in Adult Participants With Solid and Hematologic Cancers
리드: 리제네론
- 1상모집 중· Overweight or ObesitySafety and Drug Concentrations of REGN20934 in Adults With Overweight or Obesity
리드: 리제네론
- 2상모집 중· HypercholesterolemiaA Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia
리드: 리제네론
- 3상모집 중· Paroxysmal Nocturnal HemoglobinuriaA Study to Evaluate How Pozelimab + Cemdisiran Combination Therapy Works in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Whose Current Treatment is Not Working Efficiently
리드: 리제네론
- 2상모집 중· Merkel Cell Carcinoma, Stage INeoadjuvant Merkel Cell Carcinoma Therapy (Tx) With the PD-1 Inhibitor Cemiplimab
협력: 리제네론
- 1상모집 중· Healthy VolunteerFirst-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic Dermatitis
리드: 리제네론
- 2상모집 중· Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD
리드: 리제네론
- 3상모집 중· High Risk Smoldering Multiple Myeloma (HR-SMM)A Study to Compare Linvoseltamab and Daratumumab Treatment in High-Risk Smoldering Multiple Myeloma (HR-SMM)
리드: 리제네론
- 4상모집 중· Polymyalgia RheumaticaSarilumab Efficacy and Safety in Adults With Early Polymyalgia Rheumatica
리드: 사노피 · 협력: 리제네론
- 2상모집 중· Pancreatic Ductal Adenocarcinoma (mPDAC)Cemiplimab Plus Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma
협력: 리제네론
- 2상모집 중· Pulmonary Arterial Hypertension (PAH)Study of REGN13335 in Adult Participants With Pulmonary Arterial Hypertension (PAH)
리드: 리제네론
- 2상모집 중· Advanced Renal Cell Carcinoma (aRCC)A Randomized Trial of Fianlimab and Cemiplimab +/- Ipilimumab or Ipilimumab Plus Nivolumab in First-line Advanced Renal Cell Carcinoma (RCC)
협력: 리제네론
- 2상모집 중· Head and Neck Squamous Cell Carcinoma (HNSCC)A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
리드: 리제네론
- 3상모집 중· Atrial Fibrillation (AF)Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable
리드: 리제네론
- 1/2상모집 중· Relapsed Refractory Multiple Myeloma (RRMM)A Trial to Study if REGN17372 in Combination With Linvoseltamab is Tolerable for Adult Participants With Relapsed/Refractory Multiple Myeloma
리드: 리제네론
- 1/2상모집 중· Recurrent Multiple MyelomaResponse-Based Dose Reduction of Linvoseltamab in the Treatment of Relapsed, Refractory, or Triple-Class Relapsed/Refractory Multiple Myeloma
협력: 리제네론
- 단계 미표기모집 중· Chronic Spontaneous UrticariaA Study to Describe the Real-world Effectiveness, Safety and Patterns of Use of Dupilumab in Patients With Chronic Spontaneous Urticaria
리드: 사노피 · 협력: 리제네론
- 2상모집 중· Advanced/Metastatic Non-Small Cell Lung CancerA Study to Investigate Ubamatamab With and Without REGN7075 in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
리드: 리제네론
- 3상모집 중· Generalized LipodystrophyEfficacy and Safety of Mibavademab in Adult and Pediatric Patients With Generalized Lipodystrophy
리드: 리제네론
- 2상모집 중· Functional Hypothalamic Amenorrhea (FHA)A Study to Investigate Mibavademab in Adult Women With Functional Hypothalamic Amenorrhea
리드: 리제네론
- 3상모집 중· Cancer-Associated Thrombosis (CAT)REGN7508 in Adult Participants for Prevention of Cancer-Associated Thrombosis
리드: 리제네론
- 단계 미표기모집 중· Atopic DermatitisThe Impact of Dupilumab Treatment on Anxiety and Depression Symptoms in Patients With Moderate-to-Severe Atopic Dermatitis
리드: 사노피 · 협력: 리제네론
- 1/2상모집 중· Paroxysmal Nocturnal Hemoglobinuria (PNH)A First-in-Human Safety and Efficacy Study of ALN-CFB, a Small Interfering RNA (siRNA) Targeting Complement Factor B, in Adult Participants With Paroxysmal Nocturnal Hemoglobinuria With Persistent Anemia on a C5 Inhibitor
리드: 리제네론
- 3상모집 중· Asthma ControlA Study Assessing the Effect of Dupilumab on Inducing Clinical Remission in Asthma
협력: 리제네론, 사노피
- 1상모집 중· Geographic Atrophy (GA)Intravitreal (IVT) Pozelimab for Geographic Atrophy (GA) in Adult Participants
리드: 리제네론
- 2상모집 중· Clear Cell Renal Cell CarcinomaCemiplimab or Cemiplimab and Fianlimab After Stereotactic Body Radiotherapy in Clear Cell Renal Cell Carcinoma
협력: 리제네론
- 3상모집 중· Allergic ConjunctivitisStudy of Bet v1 Antibodies Effect on Eye Allergy Symptoms in Adolescents and Adults With Birch Pollen Allergy
리드: 리제네론
- 2상모집 중· Diabetic Kidney Disease (DKD)Study to Assess the Effects of Angiopoietin-like Protein 3 (ANGPTL3) Inhibition in Adult Participants With Diabetic Kidney Disease
리드: 리제네론
- 3상모집 중· Relapsed and/or Refractory Multiple Myeloma (RRMM)A Study to Compare Linvoseltamab Monotherapy and Linvoseltamab + Carfilzomib Combination Therapy With Standard-of-Care Combination Regimens in Adult Participants With Relapsed/Refractory Multiple Myeloma (RRMM)
리드: 리제네론
- 1상모집 중· Lupus Nephritis (LN)Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus Nephritis
리드: 리제네론
- 1상모집 중· Parkinsons DiseaseFirst-in-Human Study of ALN-SNCA in Adult Participants With Early Parkinson's Disease (PD)
리드: 리제네론
- 3상모집 중· Symptomatic Venous Thromboembolism (VTE)REGN7508 Versus Acetylsalicylic Acid (ASA) for Venous Thromboprophylaxis After Total Knee Arthroplasty in Adult Participants
리드: 리제네론
- 단계 미표기모집 중· Locally Advanced MelanomaOpdualag vs. Cemiplimab/Fianlimab in Relation to the Immunological Response in Tumor and Peripheral Blood in Unresectable or Metastatic Melanoma
협력: 리제네론
- 2상모집 중· NSCLC (Advanced Non-small Cell Lung Cancer)Oral Pooled Fecal Microbiotherapy (MaaT033) Concomitant to Cemiplimab Versus Best Investigator's Choice in Patients With Resistance to Treatment Due to Antibiotics Uptake With Advanced Non-small Cell Lung Cancer
협력: 리제네론
- 단계 미표기모집 중· Diabetic NephropathiesTransformative Research in Diabetic Nephropathy 2.0
협력: 아스트라제네카, GSK, 노보노디스크, 리제네론, 로슈
- 단계 미표기모집 중· Long Term Safety Following GM T Cell TherapyA Safety and Efficacy Long-Term Follow-up Study of Adult Participants Treated With Gene Modified T Cells
리드: 리제네론
- 3상모집 중· Eosinophilic Esophagitis (EoE)A Study of Dupilumab in Small Children With an Allergic Condition of the Esophagus (Food Pipe): Eosinophilic Esophagitis
리드: 리제네론 · 협력: 사노피
- 1/2상모집 중· Cutaneous Basal Cell CarcinomaCemiplimab Plus Imiquimod and Laser Therapy As Neoadjuvant Treatment In Cutaneous Basal Cell Carcinoma
협력: 리제네론
- 2상모집 중· Atrial Fibrillation (AF)Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
리드: 리제네론
- 1상모집 중· Alzheimer's DiseaseA Study to Evaluate ALN-5288 in Patients With Alzheimer's Disease
협력: 리제네론
- 4상모집 중· Chronic Obstructive Pulmonary DiseaseA Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
리드: 사노피 · 협력: 리제네론
- 2상모집 중· Recurrent Diffuse Large B-Cell LymphomaOdronextamab for Relapsed and Refractory Large B-cell Lymphomas Before CAR-T
협력: 리제네론
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.